Aims: Pharmacological-challenge magnetic resonance imaging (phMRI) is powerful new tool enabling researchers to map the central effects of neuroactive drugs in vivo. To employ this technique pre-clinically, head movements and the stress of restraint are usually reduced by maintaining animals under general anaesthesia. However, interactions between the drug of interest and the anaesthetic employed may potentially confound data interpretation. NMDA receptor (NMDAR) antagonists used widely to mimic schizophrenia have recently been shown to interact with the anaesthetic halothane. It may be the case that neural and cerebrovascular responses to NMDAR antagonists are dependent on the types of anaesthetic used. Methodology: We compared the phMRI r...
Following the discovery of the antidepressant properties of ketamine, there has been a recent resurg...
Master of ScienceDepartment of Psychological SciencesCharles Pickens IIKetamine, an NDMA receptor an...
N-methyl-D-aspartate receptor (NMDAR) hypofunction is a leading pathophysiological model of schizoph...
Since the small animal imaging generally requires anesthesia, anesthetic agents can induce unintende...
Pharmacologic MRI (phMRI) is a non-invasive in vivo imaging method, which can evaluate the drug effe...
Introduction Ketamine and phencyclidine (PCP) act as noncompetitive antagonists to the N-methyl-D-as...
Background: Anatomic sites within the brain, which activate in response to noxious stimuli, can be i...
Preclinical imaging of brain activity requires the use of anesthesia. In this study, we have compare...
Background: The aim of the present study was to evaluate the potentiation of general anaesthetic act...
The dissociative anaesthetic, ketamine, is commonly known as a NMDA receptor channel blocker. Howeve...
The state of unconsciousness during anaesthesia is not characterized by a global disruption of CNS a...
Ketamine is a clinical anesthetic and antidepressant. Although ketamine is a known NMDA receptor ant...
A growing number of studies demonstrate that antagonists of the N- methyl-D-aspartate (NMDA) recepto...
Background:Pharmacological magnetic resonance imaging has been used to investigate the neural effect...
Central nervous system is a complex machine; it is constituted by more or less 172 billions of cells...
Following the discovery of the antidepressant properties of ketamine, there has been a recent resurg...
Master of ScienceDepartment of Psychological SciencesCharles Pickens IIKetamine, an NDMA receptor an...
N-methyl-D-aspartate receptor (NMDAR) hypofunction is a leading pathophysiological model of schizoph...
Since the small animal imaging generally requires anesthesia, anesthetic agents can induce unintende...
Pharmacologic MRI (phMRI) is a non-invasive in vivo imaging method, which can evaluate the drug effe...
Introduction Ketamine and phencyclidine (PCP) act as noncompetitive antagonists to the N-methyl-D-as...
Background: Anatomic sites within the brain, which activate in response to noxious stimuli, can be i...
Preclinical imaging of brain activity requires the use of anesthesia. In this study, we have compare...
Background: The aim of the present study was to evaluate the potentiation of general anaesthetic act...
The dissociative anaesthetic, ketamine, is commonly known as a NMDA receptor channel blocker. Howeve...
The state of unconsciousness during anaesthesia is not characterized by a global disruption of CNS a...
Ketamine is a clinical anesthetic and antidepressant. Although ketamine is a known NMDA receptor ant...
A growing number of studies demonstrate that antagonists of the N- methyl-D-aspartate (NMDA) recepto...
Background:Pharmacological magnetic resonance imaging has been used to investigate the neural effect...
Central nervous system is a complex machine; it is constituted by more or less 172 billions of cells...
Following the discovery of the antidepressant properties of ketamine, there has been a recent resurg...
Master of ScienceDepartment of Psychological SciencesCharles Pickens IIKetamine, an NDMA receptor an...
N-methyl-D-aspartate receptor (NMDAR) hypofunction is a leading pathophysiological model of schizoph...